| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/17/2011 | US20110064816 Atorvastatin compositions |
| 03/17/2011 | US20110064814 Stable pharmaceutical products |
| 03/17/2011 | US20110064813 Use of salsalate with or without caffeine and with or without omega 3, and other pharmaceutical compounds in a distinctively unique nano-particulate capsule and tablet |
| 03/17/2011 | US20110064801 Pharmaceutical Formulations Containing an SGLT2 Inhibitor |
| 03/17/2011 | US20110064786 Novel use of basic fibroblast growth factor in the de-differentiation of animal connective tissue cells |
| 03/17/2011 | US20110064781 Novel heparin entities and methods of use |
| 03/17/2011 | US20110064762 Protein a compositions and methods of use |
| 03/17/2011 | US20110064757 Nucleic acid molecules and polypeptides for immune modulation |
| 03/17/2011 | US20110064705 Hemangio colony forming cells and non-engrafting hemangio cells |
| 03/17/2011 | CA2773192A1 Plgf-1 in homodimeric form |
| 03/17/2011 | CA2771452A1 Hsl inhibitors useful in the treatment of diabetes |
| 03/16/2011 | EP2295550A2 Crystal structures of GSK-3beta protein and protein complexes and their use. |
| 03/16/2011 | EP2295541A1 Pluripotent stem cell derived from cardiac tissue |
| 03/16/2011 | EP2295529A2 Use of a volatile environmental pollutants-decreasing working fluid for decreasing the amount of pollutants in a fat for alimentary or cosmetic use |
| 03/16/2011 | EP2295464A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295463A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295462A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295461A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295460A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295459A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295458A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295457A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 03/16/2011 | EP2295456A1 Albumin fusion proteins |
| 03/16/2011 | EP2295449A1 PLGF-1 in homodimeric form |
| 03/16/2011 | EP2295436A1 2-Phenyl-subsitituted Imidazotriazinones as Phosphodiesterase V inhibitors |
| 03/16/2011 | EP2295435A1 Substituted porphyrins and their therapeutic use |
| 03/16/2011 | EP2295429A1 3-((hetero)aryl)-indazoles as Liver X receptor (LXR) and Th-1 inhibitors for the treatment of cardiovascular diseases |
| 03/16/2011 | EP2295413A1 Indazole compounds useful as protein kinase inhibitors |
| 03/16/2011 | EP2295412A1 Indazole compounds useful as protein kinase inhibitors |
| 03/16/2011 | EP2295069A1 Treatment of neurological disorders with haematopoietic growth factors |
| 03/16/2011 | EP2295067A1 E-selectin for inducing immunotolerance |
| 03/16/2011 | EP2295063A2 Compositions and the use thereof the treatment of mitochondrial diseases |
| 03/16/2011 | EP2295060A2 Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/16/2011 | EP2295059A2 Stabilization of hypoxia inducible factor (HIF) alpha |
| 03/16/2011 | EP2295053A1 Novel 2H-chromen-2-one-3-carboxamides for medical uses |
| 03/16/2011 | EP2294918A1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation |
| 03/16/2011 | EP2294917A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 03/16/2011 | EP2294069A1 Therapeutically useful substituted hydropyrido ý3,2,1-ij¨quinoline compounds |
| 03/16/2011 | EP2294066A1 Benzoimidazoles as prolyl hydroxylase inhibitors |
| 03/16/2011 | EP2294056A1 Bosentan salts |
| 03/16/2011 | EP2293847A1 Depsipeptides and their therapeutic use |
| 03/16/2011 | EP2293795A1 Pharmaceutical combination |
| 03/16/2011 | EP2293792A1 Diaryl ureas for treating heart failure |
| 03/16/2011 | EP2205562B1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 03/16/2011 | EP2132194B1 Substituted isoquinolines and their use as rho-kinase inhibitors |
| 03/16/2011 | EP1565239B1 Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1] nonanes for treating anti-arrhythmic events |
| 03/16/2011 | EP1495018B3 Tricyclic thrombin receptor antagonists |
| 03/16/2011 | EP1490360B1 Thiazolidinedione derivatives and pharmaceutical composition comprising the same |
| 03/16/2011 | EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 03/16/2011 | EP1412388B1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 03/16/2011 | CN1785314B Zushi daphneol extract, its preparation method and use |
| 03/16/2011 | CN1778328B Polysatrifo Chinese medicinal oral preparation and its making method |
| 03/16/2011 | CN101986782A Substituted heteroarylamide diazepinopyrimidone derivatives |
| 03/16/2011 | CN101985478A Fusion protein and application thereof to ischemic brain stroke |
| 03/16/2011 | CN101985444A V crystal form of Fasudil hydrochloride and preparation method and application thereof |
| 03/16/2011 | CN101985420A Oleate and preparation method and applications in preparation of medicines for curing hypertension and hypertension complications thereof |
| 03/16/2011 | CN101985042A Medicinal composition for resisting thrombus |
| 03/16/2011 | CN101985041A Clopidogrel- and stanin compounds-containing medicinal composition |
| 03/16/2011 | CN101985040A Novel medicinal composition |
| 03/16/2011 | CN101985039A Medicinal composition for resisting thrombus |
| 03/16/2011 | CN101985038A Medicinal composition for resisting thrombus |
| 03/16/2011 | CN101985035A Perindopril-containing compound preparation for treating hypertension |
| 03/16/2011 | CN101985033A Compound traditional Chinese medicine for treating stubborn diseases |
| 03/16/2011 | CN101985032A Cardiac chest pain relieving paste |
| 03/16/2011 | CN101985003A Medicinal liquor with effects of tonifying kidney and holding qi |
| 03/16/2011 | CN101985000A Thrombus Chinese patent oral medicine |
| 03/16/2011 | CN101984987A Traditional Chinese medicine formula for reducing hypertension |
| 03/16/2011 | CN101984972A Benazepril-containing compound preparation for treating high blood pressure |
| 03/16/2011 | CN101984971A Drug composition containing clopidogrel and nicotinic acid compounds |
| 03/16/2011 | CN101984969A Drug composition containing clopidogrel and fibrate compounds |
| 03/16/2011 | CN101984965A Application of epicatechin gallate and derivatives thereof for treating or preventing myocardial infarction and other ischemic heart diseases |
| 03/16/2011 | CN101984959A Freeze-dried powder injection for injecting brazilein and preparation method thereof |
| 03/16/2011 | CN101698090B Traditional Chinese medicine composite for treating coma and heart syncope symptoms and preparation method thereof |
| 03/16/2011 | CN101584805B Chinese medicine preparation for treating heart failure |
| 03/16/2011 | CN101575335B Dehydrogenated silibinin substituted by meta-chlorobenzene formoxyl, preparation method and pharmaceutical applications thereof |
| 03/16/2011 | CN101554471B Traditional Chinese medicine preparation for treating myocardial infarction |
| 03/16/2011 | CN101537040B Composite for stimulating acupoint and raising blood pressure |
| 03/16/2011 | CN101367759B Synthesis of high-purity amlodipine besylate |
| 03/16/2011 | CN101362724B Tetramethylpyrazine acidamides derivates, preparation method and medicament composition and application |
| 03/16/2011 | CN101361798B Traditional Chinese medicine for treating apoplexia and flaccid paralysis |
| 03/16/2011 | CN101342314B Traditional Chinese medicine for treating cardiovascular disease, preparation method and uses thereof |
| 03/16/2011 | CN101332182B Preparation method of emulsion containing alprostadil for intravenous transfusion |
| 03/16/2011 | CN101264150B Chinese medicinal composition containing radix astragali and preparation thereof |
| 03/16/2011 | CN101194934B Method for abstracting active compound rich in echinacoside and feltwort glycoside |
| 03/15/2011 | US7906701 p300 transgenic animal |
| 03/15/2011 | US7906659 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 03/15/2011 | US7906650 Caspase inhibitors and uses thereof |
| 03/15/2011 | US7906616 Truncated DANCE, DANCE complex and method of using these |
| 03/15/2011 | US7906516 Carbonyl compounds |
| 03/15/2011 | US7906502 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 03/15/2011 | US7906150 Preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium |
| 03/15/2011 | US7906141 Sustained-release, oral pharmaceutical forms of formulation |
| 03/15/2011 | US7906133 Optimized dosing for drug coated stents |
| 03/15/2011 | CA2677910C The use of inhibitors of the renin-angiotensin system for the treatment of cardiovascular diseases |
| 03/15/2011 | CA2630665C Heterocyclic compound having inhibitory activity on 11-.beta.-hydroxysteroid dehydrogenase type i |
| 03/15/2011 | CA2577740C Method of enhancing absorptions of transmucosal administration formulations |
| 03/15/2011 | CA2562982C Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 03/15/2011 | CA2528385C A1 adenosine receptor antogonists |
| 03/15/2011 | CA2496708C New process for the synthesis of (1s)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane and its addition salts and application to the synthesis of ivabradine and its addition salts with a pharmaceutically acceptable acid |
| 03/15/2011 | CA2473910C Pyrimidine derivatives as rho-kinase inhibitors |